Just because you are Kim Kardashian, one of the most followed celebrities on social media, doesn’t mean you won’t run afoul of Food and Drug Administration guidelines on drug promotion.
The FDA fired off a warning letter to Duchesnay, Inc., makers of Diclegis, a morning sickness drug Kardashian said in an Instagram post made her feel “a lot better.”
While the post, since removed, garnered 450,000 “likes” it failed to include the risks and warnings the FDA requires must accompany ads promoting a prescription drug.
“The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information associated with its use and it omits material facts,” the FDA wrote.
Ads on social media are coming under increasing scrutiny from the government. The Federal Trade Commission, which polices false and misleading advertising, recently updated the FAQs for its endorsement guides to provide more guidance on social media and video endorsements.